920
Views
16
CrossRef citations to date
0
Altmetric
Original

Risk Factors and Prevention of End Stage Renal Disease in Uruguay

, , , &
Pages 617-625 | Published online: 07 Jul 2009

REFERENCES

  • http://www.ine.gub.uy/socio-demograficos/pobhogyviv.htm, Instituto Nacional de Estadística. Censos de Población año 2004, Montevideo, Uruguay. Instituto Nacional de Estadística. Encuesta Continua de Hogares, 1996–1997. Montevideo.
  • http://www.ine.gub.uy/socio-demograficos/pobhogyviv.htm, Instituto Nacional de Estadística. Encuesta Continua de Hogares, 1996–1997. Montevideo.
  • United Nations Development Programme. Human Development Report 2003. Oxford University Press, New York 2003
  • http://www.nefroprevencion.org.uy/rud/rudialisis.htm, Sociedad Uruguaya de Nefrologia. Registro Uruguayo de Diálisis.
  • http://www.nefroprevencion.org.uy/rud/rtrasplante.htm, Sociedad Uruguaya de Nefrologia. Registro Uruguayo de Trasplante Renal.
  • National Institutes of Health National Institute of Diabetes Digestive and Kidney Diseases. USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. US Renal Data System, Bethesda, Md 2003
  • Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746–2753, [INFOTRIEVE], [CSA]
  • Schieppati A, Perico N, Remuzzi G. Preventing end-stage renal disease: the potential impact of screening and intervention in developing countries. Nephrol Dial Transplant 2003; 18: 858–859, [INFOTRIEVE], [CROSSREF], [CSA]
  • Bianchi MJ, Fernández Cean JM, Carbonell ME, Bermúdez C, Marfredi JA, Folle LE, et al. Encuesta epidemiológica de hipertensión arterial en Montevideo: prevalencia, factores de riesgo, plan de seguimiento. Rev Med Uruguay 1994; 10: 113–120, [CSA]
  • Consenso Uruguayo de Hipertensión Arterial, 2º. Montevideo. Rev Hipertens Art 2000; 7: 3–78, [CSA]
  • Bianchi M, Nieto F, Sandoya E, Senra H. Hypertension prevalence, treatment and degree of control in an adult Uruguayan population. Hypertension 1999; 33: 1262, [CSA]
  • Schettini C, Bianchi M, Nieto F, Sandoya E, Senra H. Ambulatory blood pressure: normality and comparison with other measurements. Hypertension Working Group. Hypertension 1999; 34(4 Pt. 2)818–825, [INFOTRIEVE], [CSA]
  • Ferrero R, García MV. Encuesta de prevalencia de la diabetes en Uruguay. Primera fase: Montevideo, 2004. Arch Med Int 2005; 27: 7–12, [CSA]
  • Solá L, González C, Schwedt E, Ferreiro A, Mazzuchi N. Registro Uruguayo de Diálisis. Incidencia de Insuficiencia Renal Extrema en Uruguay: Evolución de la Etiología (1981–2002). Congreso Latinoamericano de Nefrología e Hipertensión 13º, Punta del EsteUruguay 2004
  • Mazzuchi N, Schwedt E, González MC, Solá L, Garau M, Caporale N, et al. Evaluación del programa de diálisis para el tratamiento de la insuficiencia renal crónica en el Uruguay. Arch. Med. Interna. Montevideo 2000; 22(Suppl.)S1–S72, [CSA]
  • Mazzuchi N, Schwedt E, Fernández-Cean JM, González-Martínez F, Cusumano AM, Agost-Carreño C, et al. Incidencia y prevalencia del tratamiento de la insuficiencia renal extrema en Latinoamérica. Nefrología Latinoamericana 2002; 9: 191–195, [CSA]
  • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl. 1)S1–S266, [CSA]
  • National Kidney Foundation. K/DOQI clinical practice guidelines on managing dyslipidemias in chronic kidney disease. Am J Kidney Dis 2003; 41(Suppl. 3)S1–S77, [CSA]
  • Anavekar N, Pfeffer M. Cardiovascular risk in chronic kidney disease. Kidney Int 2004; 66(Suppl. 92)S11–S15, [CROSSREF], [CSA]
  • Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154–2169, [INFOTRIEVE], [CROSSREF], [CSA]
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Breen LA, Izzo JL, Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572, [INFOTRIEVE], [CROSSREF], [CSA]
  • Burgos-Calderón R, Depine S. Sustainable and tenable renal health model: a Latin American proposal of classification, programming, and evaluation. Kidney Int 2005; 68(Suppl. 97)S23–S30, [CSA]
  • Rodríguez-Iturbe B, Bellorin-Font E. End-stage renal disease prevention strategies in Latin America. Kidney Int 2005; 68(Suppl. 98)S30–S36, [CROSSREF], [CSA]
  • http://www.isn-online.org/uploadedfiles/isn/PDF/ISN, Program for detection and management of chronic kidney disease, hypertension, diabetes and cardiovascular disease in developing countries. KHDC Program, International Society of Nephrology.
  • www.who.int/ncd_surveillance/steps/resources/es/print.html, STEPS: A framework for surveillance. The WHO STEP wise approach to Surveillance of noncommunicable diseases (STEPS). Noncommunicable Diseases and Mental Health World Health Organization, Geneva, Switzerland.
  • Perico N, Codreanu I, Schieppati A, Remuzzi G. The future of renoprotection. Kidney Int 2005; 68(Suppl. 97)S95–S101, [CROSSREF], [CSA]
  • Curtis BM, Levin A. The role of the Chronic Kidney Disease Clinic. Chronic Kidney Disease, Dialysis and Transplantation: A Companion to Brenner and Rector´s The Kidney2nd, JG Brian, M Pereira, H Sayegh, P Blake. Elsevier Saunders. 2005
  • Mazzuchi N, Acosta N, Caorsi H, Schwedt E, Di Martino LA, Mautone M, et al. Frecuencia de diagnósticos y de presentación clínica de las glomerulopatías en el Uruguay. En nombre del Programa de Prevención y Tratamiento de las Glomerulopatías. Nefrologia 2005; 25: 113–120, [INFOTRIEVE], [CSA]
  • Ríos P, Solá L, Schwedt E, Mazzuchi N. Renal healthcare: Preliminary results of the pilot program targeted to public assistance population. Prevention in Renal Disease, Fourth Annual Conference, TorontoCanada, September, 2005

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.